Does vimentin help to delineate the so-called 'basal type breast cancer'?

Table 1 Associations between clinical and histopathological features and expression of vimentin.

Feature	Vimentin-negative N = 141	Vimentin-positive N = 38	p value
Age (mean)	58.09	51.79	0.024
Tumour size			0.294
T1	43	15
T2-4	98	23
Nodal status			0.718
Negative	64	16
Positive	77	22
Grading			<0.001
G1-2	90	10
G3	51	28
ER			<0.001
Negative	70	31
Positive	71	7
PgR			<0.001
Negative	64	31
Positive	77	7
CK5/6			<0.001
Negative	109	8
Positive	32	30
CK14			<0.001
Negative	134	21
Positive	7	17
CK17			<0.001
Negative	118	16
Positive	23	22
CK5/6 or 14 o r17			<0.001
Negative	105	8
Positive	36	30
HER2			0.004
Negative	110	37
Positive	31	1
Triple negativity			<.001
Yes	25	29
No	116	9
P-cadherin			0.110
Negative	61	11
Positive	80	27
Cyclin E			0.058
Negative	65	11
Positive	76	27
Ki-67 expression, % (mean)	9.09	11.34	0.152

The second and third columns contain numbers of patients, age and Ki-67 expression excepted.

ISSN: 1756-9966